Adi Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 22 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 37.98%
- Ebitda 93.95%
- Net Worth -5.47%
- Total Assets -5.04%
About Adi Biotech
Adi Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 August 2002 and has a history of 22 years and five months. Its registered office is in Gurugram, Haryana, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Madhu Singh and Suresh Kumar serve as directors at the Company.
Company Details
-
Location
Gurugram, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899HR2002PTC034954
-
Company No.
034954
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Aug 2002
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Who are the key members and board of directors at Adi Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhu Singh
|
Director | 28-Aug-2002 | Current |
|
Suresh Kumar
|
Director | 30-Mar-2007 | Current |
Financial Performance of Adi Biotech.
Adi Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 37.98% increase in profit. The company's net worth dipped by a decrease of 5.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adi Biotech?
In 2017, Adi Biotech had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Boston Infrastructure & Development Private LimitedMadhu Singh and Suresh Kumar are mutual person
-
Param Buildwell Private Limited
Madhu Singh and Suresh Kumar are mutual person
-
Boston Reconstruction Private Limited
Madhu Singh is a mutual person
-
Onehab Solutions Private Limited
Madhu Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adi Biotech?
Unlock and access historical data on people associated with Adi Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
